Air Travel Policies and Airline Access to Epinephrine
Air travel can be particularly stressful for individuals and families managing food allergies because they do not have access to emergency medical care and airline policies on accommodations can be hard to find or inconsistently applied. In 2014, FARE convened a coalition group of patient advocacy organizations to present a unified voice regarding the steps that the airline industry can take to better accommodate passengers with food allergies. In addition to FARE, the group includes Allergy & Asthma Network, the Asthma and Allergy Foundation of America and No Nut Traveler. FARE worked with coalition partners to develop a set of key priorities.
On August 5, 2015, Sen. Mark Kirk (R-IL) and Sen. Jeanne Shaheen (D-NH) introduced the Airline Access to Emergency Epinephrine Act, (S.1972). This bipartisan federal bill addresses the key priorities identified by the coalition.
If passed, the bill would:
- Direct the U.S. Government Accountability Office (GAO) to conduct and submit a report to Congress on air carrier policies relating to passengers with food allergies
- Require airlines to carry epinephrine auto-injectors, and to train crewmembers to recognize the symptoms of an acute allergic reaction and to administer auto-injectable epinephrine
- Instruct the Federal Aviation Administration and individual airlines to clarify that the 1:1,000 epinephrine ampules that are currently included in emergency medical kits are intended to be used for the treatment of anaphylaxis.
Learn more about the bill by reading our press release.
Help us get this important bill passed into law! Take action by signing up for the FARE Advocates Network at www.foodallergyadvocacy.org.